Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

Share Price is delayed by 15 minutes
Get Live Data
2,340.00    1.00 (0.04%)
Bid:
2,342.00
Ask:
2,344.00
Spread: 2.00 (0.085%)
Market Cap: £3.91b
WTB Live PriceLast checked at - London Stock Exchange

Intraday Whitbread Share Chart

Share repurchase programme

18 Oct 2023 07:10

RNS Number : 4430Q
Whitbread PLC
18 October 2023
 

 

 

 

SHARE REPURCHASE PROGRAMME

 

 

As announced in today's interim results announcement, Whitbread PLC ('Whitbread' or the 'Company') is commencing a share buy-back programme of up to £300 million (the 'Programme'). The purpose of the Programme is to reduce the capital of Whitbread by returning surplus capital to shareholders and it is expected that the implementation of the Programme will enhance earnings per share. Whitbread has instructed Morgan Stanley & Co. International Plc ('Morgan Stanley') and J.P. Morgan Securities plc ('JPMS'), together the 'Brokers', to execute the Programme.

 

Whitbread has entered into a non-discretionary and irrevocable instruction with Morgan Stanley in relation to the purchase by Morgan Stanley, acting as riskless principal during the period commencing today and ending no later than 23 January 2024, of the Company's Ordinary Shares of 76 122/153 pence each ('Ordinary Shares') for an aggregate purchase price of up to £150 million. Following completion, or any termination of such instruction, the Programme will continue under a second non-discretionary and irrevocable instruction with JPMS) in relation to the purchase by JPMS, acting as riskless principal during the period commencing following the end of the Morgan Stanley instruction and ending no more than three months later, subject to suspension for certain exceptional and/or unforeseen circumstances, of further Ordinary Shares for an aggregate purchase price of up to £150 million.

 

The aggregate purchase price of the Ordinary Shares bought by the Brokers under the two instructions shall be no greater than £300 million. Each of the Brokers shall make a simultaneous on-sale of Ordinary Shares purchased under the instructions to Whitbread. The Brokers will make their trading decisions in relation to the Programme independently of, and uninfluenced by, Whitbread.

 

The maximum number of Ordinary Shares that can be purchased under the Programme is 14,138,162 Ordinary Shares (based on authority granted at Whitbread's 2023 Annual General Meeting).

 

Any purchase of Ordinary Shares made by the Brokers in relation to the Programme will be carried out on the London Stock Exchange plc, Cboe Europe Limited or Aquis Stock Exchange Limited. The buy-back by Whitbread will be executed in accordance with the Listing Rules and Whitbread's general authority (from time to time) to make market purchases of Ordinary Shares. The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures. Whitbread will announce any purchase by it of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. Ordinary Shares purchased under the Programme will be cancelled or (to the extent permitted by law) held in treasury.

 

The Brokers may undertake transactions in shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the period of the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by the relevant Broker as a result of or as part of the Programme, but the Brokers will continue to make any disclosures they are otherwise legally required to make.

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For more information please contact:

Investor Relations - Whitbread investorrelations@whitbread.com

 

Media - Teneo whitbread@teneo.com

Jessica Reid +44 (0) 20 7353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMRBRTMTABBBJ
Date   Source Headline
27th Apr 20238:59 amRNSHolding(s) in Company
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20239:07 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20234:45 pmRNSDirector/PDMR Shareholding
25th Apr 20237:04 amRNSShare repurchase programme
25th Apr 20237:00 amRNSPreliminary Results Announcement
21st Apr 20239:41 amRNSHolding(s) in Company
20th Apr 20239:01 amRNSHolding(s) in Company
19th Apr 20239:10 amRNSHolding(s) in Company
18th Apr 202311:41 amRNSHolding(s) in Company
17th Apr 20239:23 amRNSHolding(s) in Company
14th Apr 20239:00 amRNSHolding(s) in Company
11th Apr 20239:01 amRNSHolding(s) in Company
11th Apr 20238:59 amRNSHolding(s) in Company
3rd Apr 20233:05 pmRNSTotal Voting Rights
3rd Mar 202312:08 pmRNSDirector/PDMR Shareholding
1st Mar 20232:37 pmRNSTotal Voting Rights
28th Feb 202311:31 amRNSDirector/PDMR Shareholding
27th Feb 20233:58 pmRNSDirector/PDMR Shareholding
27th Feb 20233:58 pmRNSDirector/PDMR Shareholding
15th Feb 20232:28 pmRNSDirector/PDMR Shareholding
8th Feb 20232:51 pmRNSDirector/PDMR Shareholding
1st Feb 20232:38 pmRNSTotal Voting Rights
1st Feb 20231:17 pmRNSDirector/PDMR Shareholding
25th Jan 202310:01 amRNSBlock listing Interim Review
24th Jan 20239:02 amRNSDirectorate Change
17th Jan 202312:26 pmRNSDirector/PDMR Shareholding
16th Jan 20234:42 pmRNSDirector/PDMR Shareholding
13th Jan 20233:55 pmRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSQ3 FY23 Trading Update
9th Jan 20234:29 pmRNSDirectorate Change
20th Dec 202212:56 pmRNSDirector/PDMR Shareholding
5th Dec 202211:46 amRNSAppointment of Dominic Paul as CEO
1st Dec 20221:54 pmRNSTotal Voting Rights
15th Nov 20224:21 pmRNSDirector/PDMR Shareholding
7th Nov 20224:21 pmRNSDirector/PDMR Shareholding
27th Oct 202211:19 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSWhitbread Interim Results
3rd Oct 20224:23 pmRNSHolding(s) in Company
3rd Oct 20224:22 pmRNSHolding(s) in Company
3rd Oct 202210:32 amRNSTotal Voting Rights
1st Sep 202210:36 amRNSTotal Voting Rights
24th Aug 20229:51 amRNSDirector/PDMR Shareholding
24th Aug 20228:00 amRNSMajor freehold purchase in central London
1st Aug 202211:00 amRNSTotal Voting Rights
25th Jul 20229:07 amRNSBlock listing Interim Review
21st Jul 20227:10 amRNSDirector Declaration
11th Jul 20221:39 pmRNSDirector/PDMR Shareholding
1st Jul 20223:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.